Paloma Partners’s Antares Pharma, Inc. ATRS Stock Holding History

Paloma Partners’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-28,844	Closed	-$115K	–	2459
2020 Q4	$115K	Sell	28,844 -10,336	-26%	-$33.4K	﹤0.01%	1490
2020 Q3	$106K	Buy	+39,180	New	+$108K	﹤0.01%	1898
2020 Q2	–	Sell	-17,109	Closed	-$40K	–	2303
2020 Q1	$40K	Buy	+17,109	New	+$58.2K	﹤0.01%	1129
2019 Q4	–	Sell	-13,738	Closed	-$46K	–	2620
2019 Q3	$46K	Buy	+13,738	New	+$45.2K	﹤0.01%	1880
2019 Q2	–	Sell	-37,200	Closed	-$113K	–	2310
2019 Q1	$113K	Buy	+37,200	New	+$121K	﹤0.01%	1586
2016 Q3	–	Sell	-578,054	Closed	-$607K	–	2224
2016 Q2	$607K	Buy	+578,054	New	+$558K	0.01%	1442
2015 Q1	–	Sell	-40,881	Closed	-$105K	–	1494
2014 Q4	$105K	Buy	+40,881	New	+$91.8K	﹤0.01%	1064

Other funds holding ATRS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return

CWM

Centric Wealth Management Chicago, Illinois $501M AUM 15.27% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Paloma Partners's ATRS Position: Q1 2021 in Review

Paloma Partners sold out of Antares Pharma, Inc. (ATRS) in Q1 2021, closing a stake of 28,844 shares — an estimated $115K sold.

Paloma Partners first reported a position in ATRS in Q4 2014 and held it in 7 quarters. The position peaked at $607K in Q2 2016. 171 funds tracked by Wall St. Rank hold ATRS as of Q1 2021.

Paloma Partners reported no remaining Antares Pharma, Inc. position as of Q1 2021 after selling out during the quarter.
Paloma Partners sold 28,844 Antares Pharma, Inc. shares in Q1 2021, an estimated $115K.
Paloma Partners first reported a position in Antares Pharma, Inc. in Q4 2014 and held it in 7 quarters.
Paloma Partners's Antares Pharma, Inc. position peaked at $607K in Q2 2016.
171 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q1 2021.

Based on Paloma Partners's 13F filing for Q1 2021, filed 17 May 2021.